EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS063-00486 
Organism
Homo sapiens 
Tissue/cell
GM18505 
Coordinate
chr1:161581310-161583360 
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr1:161582764-161582782CCTCCCTTCCTTCCTTTG-6.66
EWSR1-FLI1MA0149.1chr1:161582760-161582778CTTTCCTCCCTTCCTTCC-9.01
KLF5MA0599.1chr1:161582351-161582361GGGGCGGGGC-6.02
ZNF263MA0528.1chr1:161582760-161582781CTTTCCTCCCTTCCTTCCTTT-6.12
ZNF263MA0528.1chr1:161582205-161582226TGAGGAGTGCGGGGGGGAAGA+6.2
Number of super-enhancer constituents: 14             
IDCoordinateTissue/cell
SE_07357chr1:161580788-161584698Brain_Hippocampus_Middle_150
SE_09867chr1:161579384-161583530CD14
SE_12235chr1:161581303-161583400CD3
SE_12654chr1:161581792-161582273CD34_adult
SE_12771chr1:161581912-161582301CD34_fetal
SE_12771chr1:161582578-161582932CD34_fetal
SE_13494chr1:161579645-161584358CD34_Primary_RO01536
SE_15335chr1:161579226-161584686CD4_Memory_Primary_7pool
SE_16693chr1:161581295-161583416CD4_Naive_Primary_8pool
SE_20036chr1:161580924-161584169CD56
SE_20740chr1:161577990-161584457CD8_Memory_7pool
SE_22436chr1:161580812-161584433CD8_primiary
SE_39938chr1:161580902-161584380K562
SE_53727chr1:161580858-161583334Spleen
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr1161582451161582780
chr1161582212161582506
chr1161581400161582169
Number: 1             
IDChromosomeStartEnd
GH01I161611chr1161580791161583390
Enhancer Sequence
GCGTTAGCGT TAAAAAAAAA ACCCAGCTAA GACTGTAGAG CAAATTAAAG GATCCTGTGT 60
TGAGGGCGTT CTCTTGTTTA GTCAAAGGAG ATGGTATCTG CCTGCCTTAG TGTGCTTGAC 120
GCACAGAAAG GGCTCAACAC ATTGTTGTTG AATAAAAGAA TGGATAAATT GACACTGGGA 180
AGTTGGAGTC CAAAGTTAAA CTTAGTCTCA ACTGCTCCCT GTTTTCATAG ACCAGACTCC 240
AGCCTACAAT ACAGGAAAAA TAGATTTAGT TCTATATGTG CAGAGAAGCA CAAATAATTT 300
TCGTAAATGT AGATACCCAG GATAAAACGC AGTGTTGACC GATCGAAAAG TCTTTCTCTA 360
AGAATTCAAA CATAATTGCT GGTTGGTTCA AATCAGGAGG AAAAGTAAGG ATGGAAAACA 420
TACGTTGTCA AAAGTGGGAT TCGAACCCAC GCCTCCAGCG GAGGGTGCGA TTTGAACGCA 480
GCGCCTTAAG ACTGCTCGGC CATCCTGACA CACGTTTTGC TAAACTTCCT AATTTCTCCT 540
AATTTTATCA TATACTGATG GTGCACGCTA TCAGGTCACA TTAATGTGTC TATTTACTGT 600
TTCAAATAAA ATTGTAACTC TCTCTAGACC TTGTCGCAAA GCGGGAAAAA TGAAACAGCC 660
TCCGACAGCT CTTTCCTCTT TCCTCACTAC CCAAACTAAA CCTTAAGGCT CCATTTTCCC 720
TGGCGACTCT TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT CGAGCCATGT CAAGGTAGAC 780
CCTGTGTCGG CCCGTCTCCC TCGGATCCTC CGCACCAATC ACTGTTGCTG AATCCGACAC 840
CCGGCGGATC CAGTGCGGAG TCTCGAACAG CTGCGGAGCT GGGAGCTACG GGACATGAGG 900
AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG AAAATCCCCC GGCGGTGCTC AACTGCGGCT 960
TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC AGAGCAAGTG GCTTCTGCGT 1020
TCACCGCCCC CCGCCGTTTG TGGGGCGGGG CCGATTCATA AGAATCGGTT CTCACCAATG 1080
GAGGGCTTAG CATGTTTAAC CTCAGGATCA TAAACAAAAG ACACTGCTAG AACGGTCGGG 1140
AAAGTCATAC GCTTTGCTTA TCTTATATAT AGATTTCTAA AATTCCAAAC CGGGGACGCG 1200
TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT TAACGCGGGT TCGATTCCCG 1260
GGTAACGAAA CGTTTTTGTC TTTCCTTCTA CGAAAAACTT TTCTGAGCCG GAGCCTCCAG 1320
CGCGCTGTGT ATTCGTTTTA CGCCTCAACG AAACTGCAGC AATACCTCAC TTTCCGTACT 1380
CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC TTTTTTTGAA GGGATTAAAT 1440
TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC CAACTCTTGA GGAATCTTTG 1500
GGATCATTTC AATCCTGGGA TGAGTCTTAG CTTCAGAAAG GGGCTCTTGT GTCTTCACTT 1560
GCGAGGTTCA TTCGCTAGCC TCTACAAATC ATCACTTAAG CCCCTAATTA TTCCCGGCCG 1620
AGGTCCTAGG CTAAGGTCCC GGGCCAAGCT TTCTAATTAG TCCCAGGCCA AGGTCCCAGG 1680
CCAACCTAAA TCACGCATTC TCCAAAACAG CCGGCAAACT AAGCACATTC CTTCCCGTTT 1740
CCAGTCCATA AACCCCCCCC CCCAAGTGGC CTCATAGTAA GCAACTCATT CGGGCCCCCT 1800
CTCTGCTGGC AAAAAGCTCA GATGTACTGG ACTGTGCATT TGATTTGGAA CTGAGTTACA 1860
TGGGAGAGAA GCAGGGATTC AGTTTGGCTG GGAATCAAAC TCTTTTGATA ATTTCCTAAT 1920
AAACTGATAG TCATTAGATG ACTTGTAGTC TCGATAAGTT GAAACTTTTT CCTAACATGC 1980
TGTTTATGAT ACTGAGTTCT TTGTCACCGG TTGAACTAAC AGCAATTGTA TTCACAAATT 2040
TTCCAGCCTT 2050